About: Anti-Cancer Drugs     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatPublicationsEstablishedIn1990, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FAnti-Cancer_Drugs

Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy.

AttributesValues
rdf:type
rdfs:label
  • Anti-Cancer Drugs (en)
  • Anti-Cancer Drugs (de)
  • Anti-Cancer Drugs (nl)
rdfs:comment
  • Anti-Cancer Drugs ist eine wissenschaftliche Fachzeitschrift, die vom Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit zehn Ausgaben im Jahr. Es werden Arbeiten veröffentlicht, die sich mit therapeutischen gegen Krebs beschäftigen. Der Impact Factor lag im Jahr 2016 bei 2,32. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Onkologie an 143. Stelle von 217 Zeitschriften und in der Kategorie Pharmakologie und Pharmazie an 162. Stelle von 254 Zeitschriften geführt. (de)
  • Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. (en)
  • Anti-Cancer Drugs (ook Anticancer drugs) is een internationaal, aan collegiale toetsing onderworpen wetenschappelijk tijdschrift op het gebied van de oncologie en de farmacologie. Het wordt uitgegeven door Lippincott Williams & Wilkins en verschijnt 10 keer per jaar. (nl)
foaf:name
  • Anti-Cancer Drugs (en)
foaf:homepage
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
impact
abbreviation
  • Anti-Cancer Drugs (en)
discipline
editor
  • Mels Sluyser (en)
frequency
history
ISSN
language
  • English (en)
publisher
title
  • Anti-Cancer Drugs (en)
website
has abstract
  • Anti-Cancer Drugs ist eine wissenschaftliche Fachzeitschrift, die vom Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit zehn Ausgaben im Jahr. Es werden Arbeiten veröffentlicht, die sich mit therapeutischen gegen Krebs beschäftigen. Der Impact Factor lag im Jahr 2016 bei 2,32. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Onkologie an 143. Stelle von 217 Zeitschriften und in der Kategorie Pharmakologie und Pharmazie an 162. Stelle von 254 Zeitschriften geführt. (de)
  • Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. (en)
  • Anti-Cancer Drugs (ook Anticancer drugs) is een internationaal, aan collegiale toetsing onderworpen wetenschappelijk tijdschrift op het gebied van de oncologie en de farmacologie. Het wordt uitgegeven door Lippincott Williams & Wilkins en verschijnt 10 keer per jaar. (nl)
eISSN
impact-year
impact factor
impact factor as of
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
abbreviation
  • Anti-Cancer Drugs
first publication year
frequency of publication
  • 10/year
issn
  • 0959-4973
  • 1473-5741
academic discipline
publisher
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software